Cargando…

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

PD-L1 on the surface of tumor cells binds its receptor PD-1 on effector T cells, thereby suppressing their activity. Antibody blockade of PD-L1 can activate an anti-tumor immune response leading to durable remissions in a subset of cancer patients. Here, we describe an alternative mechanism of PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poggio, Mauro, Hu, Tianyi, Pai, Chien-Chun, Chu, Brandon, Belair, Cassandra D., Chang, Anthony, Montabana, Elizabeth, Lang, Ursula E., Fu, Qi, Fong, Lawrence, Blelloch, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499401/ https://www.ncbi.nlm.nih.gov/pubmed/30951669 http://dx.doi.org/10.1016/j.cell.2019.02.016

Ejemplares similares

High-throughput, Efficient, and Unbiased Capture of Small RNAs from Low-input Samples for Sequencing
por: Belair, Cassandra D., et al.
Publicado: (2019)

LIN28B Impairs the Transition of hESC-Derived β Cells from the Juvenile to Adult State
por: Zhou, Xin, et al.
Publicado: (2019)

miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance
por: Wang, Siao-Yi, et al.
Publicado: (2014)

A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
por: Wang, Guohao, et al.
Publicado: (2021)

The RNA exosome nuclease complex regulates human embryonic stem cell differentiation
por: Belair, Cedric, et al.
Publicado: (2019)

Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1
por: Chen, Yanzhen, et al.
Publicado: (2023)

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
por: Chen, Gang, et al.
Publicado: (2018)

Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance
por: Vautrot, Valentin, et al.
Publicado: (2021)

The role of exosomal PD-L1 in tumor immunotherapy
por: Wang, Jing, et al.
Publicado: (2021)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

The role of exosomal PD-L1 in tumor progression and immunotherapy
por: Xie, Feiting, et al.
Publicado: (2019)

Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
por: Ayala-Mar, Sergio, et al.
Publicado: (2021)

Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020)

Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents
por: Turiello, Roberta, et al.
Publicado: (2022)

Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant
por: Lin, Ze, et al.
Publicado: (2021)

Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memory
por: Kazanova, Alexandra, et al.
Publicado: (2021)

Detection of Exosomal PD-L1 RNA in Saliva of Patients With Periodontitis
por: Yu, Jialiang, et al.
Publicado: (2019)

Exosomal PD-L1 functions as an immunosuppressant to promote wound healing
por: Su, Dandan, et al.
Publicado: (2019)

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
por: Tang, Yanyan, et al.
Publicado: (2020)

GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages
por: Chen, Jinhong, et al.
Publicado: (2021)

Correction: Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents
Publicado: (2023)

Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer
por: Wu, Hao, et al.
Publicado: (2016)

Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
por: Dou, Dongwei, et al.
Publicado: (2020)

A protease-mediated switch regulates the growth of magnetosome organelles in Magnetospirillum magneticum
por: Wan, Juan, et al.
Publicado: (2022)

Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
por: Cordonnier, Marine, et al.
Publicado: (2020)

The PD-1:PD-L1 axis in Inflammatory Arthritis
por: Canavan, Mary, et al.
Publicado: (2021)

Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
por: Hao, Qiongyu, et al.
Publicado: (2022)

microRNA induced transdifferentiation
por: Shenoy, Archana, et al.
Publicado: (2012)

Genomic Analysis Suggests that mRNA Destabilization by the Microprocessor Is Specialized for the Auto-Regulation of Dgcr8
por: Shenoy, Archana, et al.
Publicado: (2009)

Single nuclei RNA-seq of mouse placental labyrinth development
por: Marsh, Bryan, et al.
Publicado: (2020)

Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
por: Li, Xiang, et al.
Publicado: (2022)

Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
por: Yin, Zi, et al.
Publicado: (2021)

Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development
por: Xiao, Xiyun, et al.
Publicado: (2022)

Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
por: Li, Chuling, et al.
Publicado: (2019)

Exosomal PD-L1: an effective liquid biopsy target to predict immunotherapy response
por: Song, Yanling, et al.
Publicado: (2019)

In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
por: Lu, Chih-Hao, et al.
Publicado: (2022)

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
por: Del Re, Marzia, et al.
Publicado: (2018)

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
por: Qiu, Yufan, et al.
Publicado: (2021)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6hp3rlm1ghtg5bivtfcis1q94